Anti-acid treatment in patients with IPF: interpret results from post-hoc, subgroup, and exploratory analyses with great caution - Authors' reply
- PMID: 27599251
- DOI: 10.1016/S2213-2600(16)30235-1
Anti-acid treatment in patients with IPF: interpret results from post-hoc, subgroup, and exploratory analyses with great caution - Authors' reply
Comment on
-
Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis.Lancet Respir Med. 2016 May;4(5):381-9. doi: 10.1016/S2213-2600(16)00067-9. Epub 2016 Mar 31. Lancet Respir Med. 2016. PMID: 27050871
-
Anti-acid treatment in patients with IPF: interpret results from post-hoc, subgroup, and exploratory analyses with great caution.Lancet Respir Med. 2016 Sep;4(9):e46-e47. doi: 10.1016/S2213-2600(16)30234-X. Lancet Respir Med. 2016. PMID: 27599250 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
